Skip to main content
Equibles
ATNM logo

ATNM · Actinium Pharmaceuticals, Inc. · Metrics

Track ATNM — free

Use ATNM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATNM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.31 +0.00 (+0.00%)
Rebalance outlook locked
Market Cap
$38.67M
Shares
31.44M

ATNM metrics

54 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.31
Market cap
$38.67M

Price action

20 metrics
Price change (1W)
+23.0%
Price change (30D)
+55.1%
Price change (3M)
+17.1%
Price change (6M)
+4.2%
Price change (YTD)
-9.6%
Price change (1Y)
-23.1%
Trailing year
Price change (5Y)
-79.9%
52-week high
$1.69
52-week low
$0.75
Change from 52-week high
-27.2%
Change from 52-week low
+64.2%
Annualized volatility
68.3%
Annualized volatility (3M)
74.3%
Beta
0.7
RSI (14D)
71.0
Price vs SMA 50
+29.3%
Price vs SMA 200
+6.1%
Avg volume (3M)
140,862
Relative volume
2.6
Average dollar volume
$139,002

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
31.44M

Valuation

12 metrics
P / E (TTM)
3.5
Trailing earnings · reciprocal yield 28.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.3
reciprocal yield 78.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
29.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-40,274.4%
Trailing 12 months
Net margin
-37,652.2%
Gross profit (TTM)
$0
Operating profit (TTM)
$9.56M
Net income (TTM)
$11.31M
Trailing 12 months
Diluted EPS (TTM)
$0.35
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.25

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
-55.6%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
37.3%
Return on assets
28.2%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
$9.78M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
-3.7
Return on invested capital
—
Trailing 12 months
Net cash
$36.47M
Latest balance sheet
Cash & equivalents
$36.47M
Total assets
$40.16M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.66M
Capital expenditures (TTM)
—
R&D (TTM)
$18.12M
SG&A (TTM)
—
Stock compensation (TTM)
$248,000
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
48
13F filer change QoQ
-7
Institutional ownership
16.9%

Short interest

3 metrics
Short interest
2.1%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
81 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1388320 CUSIP 00507W206 13F (30d) 30 filings 30 filers Visit website Investor relations